Table 2.
Clinical outcomes, requirement of therapeutic procedures and medical expense in hospitalized patients with ALF during 2009–2013
| Survived ≥ 30 days (n = 15,087) | Died within 30 days (n = 5502) | p-value | |
|---|---|---|---|
| Length of stay (days) | 9.7 ± 15.6 | 6.1 ± 6.5 | < 0.001 |
| Complication | |||
| Acute renal failure, n (%) | 2062 (13.7%) | 2923 (53.1%) | < 0.001 |
| Septicemia, n (%) | 1703 (11.3%) | 2041 (37.1%) | < 0.001 |
| Pneumonia, n (%) | 1370 (9.1%) | 1156 (21.0%) | < 0.001 |
| Urinary tract infection, n (%) | 585 (3.9%) | 290 (5.3%) | < 0.001 |
| Procedure during admission | |||
| Liver transplantation, n (%) | 1 (0.00007%) | 0 | 0.55 |
| Renal dialysis, n (%) | 188 (1.2%) | 309 (5.6%) | < 0.001 |
| Ventilator, n (%) | 1125 (7.5%) | 2895 (52.6%) | < 0.001 |
| Antibiotic usage, n (%) | 381(2.53%) | 156(2.84%) | 0.22 |
| Blood transfusion, n (%) | 2470(16.4%) | 2068(37.6%) | < 0.001 |
| Plasma exchange, n (%) | 3(0.02%) | 8 (0.14%) | 0.001 |
| Costs per admission (USD) | 959.4 ± 2884.1 | 1392.8 ± 2172.3 | < 0.001 |
USD United States dollars